Reduced order modeling and analysis of the human complement system.

Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models....

Full description

Bibliographic Details
Main Authors: Adithya Sagar, Wei Dai, Mason Minot, Rachel LeCover, Jeffrey D Varner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5695804?pdf=render
id doaj-88cf2030ba4446c793c86c4686e1fa2f
record_format Article
spelling doaj-88cf2030ba4446c793c86c4686e1fa2f2020-11-25T00:02:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011211e018737310.1371/journal.pone.0187373Reduced order modeling and analysis of the human complement system.Adithya SagarWei DaiMason MinotRachel LeCoverJeffrey D VarnerComplement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models. We combined ordinary differential equations with logical rules to produce a compact yet predictive model of complement activation. The model, which described the lectin and alternative pathways, was an order of magnitude smaller than comparable models in the literature. We estimated an ensemble of model parameters from in vitro dynamic measurements of the C3a and C5a complement proteins. Subsequently, we validated the model on unseen C3a and C5a measurements not used for model training. Despite its small size, the model was surprisingly predictive. Global sensitivity and robustness analysis suggested complement was robust to any single therapeutic intervention. Only the simultaneous knockdown of both C3 and C5 consistently reduced C3a and C5a formation from all pathways. Taken together, we developed a validated mathematical model of complement activation that was computationally inexpensive, and could easily be incorporated into pre-existing or new pharmacokinetic models of immune system function. The model described experimental data, and predicted the need for multiple points of therapeutic intervention to fully disrupt complement activation.http://europepmc.org/articles/PMC5695804?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Adithya Sagar
Wei Dai
Mason Minot
Rachel LeCover
Jeffrey D Varner
spellingShingle Adithya Sagar
Wei Dai
Mason Minot
Rachel LeCover
Jeffrey D Varner
Reduced order modeling and analysis of the human complement system.
PLoS ONE
author_facet Adithya Sagar
Wei Dai
Mason Minot
Rachel LeCover
Jeffrey D Varner
author_sort Adithya Sagar
title Reduced order modeling and analysis of the human complement system.
title_short Reduced order modeling and analysis of the human complement system.
title_full Reduced order modeling and analysis of the human complement system.
title_fullStr Reduced order modeling and analysis of the human complement system.
title_full_unstemmed Reduced order modeling and analysis of the human complement system.
title_sort reduced order modeling and analysis of the human complement system.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models. We combined ordinary differential equations with logical rules to produce a compact yet predictive model of complement activation. The model, which described the lectin and alternative pathways, was an order of magnitude smaller than comparable models in the literature. We estimated an ensemble of model parameters from in vitro dynamic measurements of the C3a and C5a complement proteins. Subsequently, we validated the model on unseen C3a and C5a measurements not used for model training. Despite its small size, the model was surprisingly predictive. Global sensitivity and robustness analysis suggested complement was robust to any single therapeutic intervention. Only the simultaneous knockdown of both C3 and C5 consistently reduced C3a and C5a formation from all pathways. Taken together, we developed a validated mathematical model of complement activation that was computationally inexpensive, and could easily be incorporated into pre-existing or new pharmacokinetic models of immune system function. The model described experimental data, and predicted the need for multiple points of therapeutic intervention to fully disrupt complement activation.
url http://europepmc.org/articles/PMC5695804?pdf=render
work_keys_str_mv AT adithyasagar reducedordermodelingandanalysisofthehumancomplementsystem
AT weidai reducedordermodelingandanalysisofthehumancomplementsystem
AT masonminot reducedordermodelingandanalysisofthehumancomplementsystem
AT rachellecover reducedordermodelingandanalysisofthehumancomplementsystem
AT jeffreydvarner reducedordermodelingandanalysisofthehumancomplementsystem
_version_ 1725438996017840128